Eastside Specialty Ctr-Uw Med is categorized under Clinics in Bellevue, WA .
Eastside Specialty Ctr-Uw Med was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Pat Maxwell, Office Manager at the company’s single location by writing to 1700 116th Avenue Ne, Bellevue, Washington WA 98004 or by phoning (425) 646-7777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eastside Specialty Ctr-Uw Med |
| Contact Person: | Pat Maxwell, Office Manager |
| Address: | 1700 116th Avenue Ne, Bellevue, Washington 98004 |
| Phone Number: | (425) 646-7777 |
| Website Address: | uwmedicine.org |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Eastside Specialty Ctr-Uw Med was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Pat Maxwell, Office Manager for inquiries that concern Eastside Specialty Ctr-Uw Med by calling the company number (425) 646-7777, as your correspondence is most welcome. Additionally, the physical location of the single location of Eastside Specialty Ctr-Uw Med can be found at the coordinates 47.6258,-122.1856 as well as the street address 1700 116th Avenue Ne in Bellevue, Washington 98004.
For its online presence, you may visit Eastside Specialty Ctr-Uw Med’s website at uwmedicine.org and engage with its social media outlets through on Twitter and on Facebook.